Editorial |

Current Immunotherapy for Demyelinating Diseases

Khurram Bashir, MD, MPH; John N. Whitaker, MD
Arch Neurol. 2002;59(5):726-731. doi:10.1001/archneur.59.5.726.
Text Size: A A A
Published online


DEMYELINATION IS the partial or total loss of the myelin sheath of nerve fibers following normal myelin development. Multiple sclerosis (MS) is the most common acquired inflammatory demyelinating disease of the central nervous system. The presumed immune-mediated nature of demyelinating diseases prompted evaluation of immunomodulatory and immunosuppressive agents for their treatment. The management of demyelinating diseases, in particular MS, has evolved significantly during the last decade. This has shifted the emphasis from treatment of acute relapses and management of symptoms to pharmacotherapy aimed at altering the natural history of the disease. Current relapse therapy, with glucocorticoids, had its origin in the 1950s and is used to accelerate recovery with no clear impact on the degree of improvement from acute neurologic dysfunction. For more than 100 years, symptom management has used unapproved or off-label uses of agents, with their expected benefit based on anecdotal reports or small case series. These interventions, although successful in improving the quality of life of patients with MS, did not alter the natural history of MS.1 The ability to favorably modify the number of relapses of MS began in 1993 when interferon beta-1b was approved by the Food and Drug Administration for the treatment of relapsing-remitting (RR) MS. Since then, additional agents such as interferon beta-1a, glatiramer acetate (previously copolymer-1), and mitoxantrone hydrochloride have become available for the treatment of patients with MS. These immunomodulatory and immunosuppressive agents, although only partially effective, are beneficial in reducing relapses, preventing disability, and stabilizing magnetic resonance imaging (MRI) changes in patients with MS.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 7

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles